Comparison of allergy immunotherapy medication persistence with a sublingual immunotherapy tablet versus subcutaneous immunotherapy in Germany - 04/05/18
Supported by ALK-Abelló. |
|
Disclosure of potential conflict of interest: J.-P. Allam is employed by and received payment for lectures from ALK-Abelló, HAL, and Stallergenes. J. N. Andreasen and J. Mette are employed by ALK-Abelló. N. Serup-Hansen is employed by and has stock options with ALK-Abelló A/S. E. G. Wüstenberg is employed by and has stock options with ALK-Abelló. |
Vol 141 - N° 5
P. 1898 - mai 2018 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?